SCHEMBL9501032

SCHEMBL9501032

CCC=C(CCC)CCC

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
FFAR3 O14843 3/20 0.33
HDAC3 O15379 3/20 0.33
HDAC1 Q13547 3/20 0.33
HDAC2 Q92769 3/20 0.33
HDAC8 Q9BY41 3/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2004315 0.88
SCHEMBL2004313 0.88
SCHEMBL20355780 0.87
SCHEMBL5985535 0.87
SCHEMBL5985529 0.87
SCHEMBL14646884 0.87 TSHR (0.31) TSHR
SCHEMBL6748303 0.85
SCHEMBL12654720 0.85
SCHEMBL11790531 0.84 CES2 (0.42) CES2CES1ALDH1A1TDP1TSHR
SCHEMBL844995 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119822958-B Method for preparing high-carbon ester compound by combining electrocatalytic and thermocatalytic crude acetylene and two-step cascading device 中国科学技术大学 2025-06-13 CN disclosed
CN-119822958-A Method for preparing high-carbon ester compound by combining electrocatalytic and thermocatalytic crude acetylene and two-step cascading device 中国科学技术大学 2025-04-15 CN disclosed
US-11384056-B2 Method for the manufacturing of delmopinol intermediates LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) 2022-07-12 US disclosed
CN-110831997-B Mixtures of radically curable compounds and their use 喜利得股份公司 2022-02-22 CN disclosed
EP-3558952-B1 METHOD FOR THE MANUFACTURING OF DELMOPINOL AND OF ITS INTERMEDIATES LUNDBECK PHARMACEUTICALS ITALY S P A (IT) 2022-02-09 EP disclosed
US-20210130307-A1 METHOD FOR THE MANUFACTURING OF DELMOPINOL INTERMEDIATES LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) 2021-05-06 US disclosed
EP-3558951-B1 METHOD FOR THE MANUFACTURING OF DELMOPINOL LUNDBECK PHARMACEUTICALS ITALY S P A (IT) 2021-04-14 EP disclosed
US-10894778-B2 Method for the manufacturing of delmopinol LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) 2021-01-19 US disclosed
EP-3558951-A1 METHOD FOR THE MANUFACTURING OF DELMOPINOL Lundbeck Pharmaceuticals Italy S.p.A. (IT) 2019-10-30 EP disclosed
EP-3558952-A1 METHOD FOR THE MANUFACTURING OF DELMOPINOL INTERMEDIATES Lundbeck Pharmaceuticals Italy S.p.A. (IT) 2019-10-30 EP disclosed
WO-2018115116-A1 METHOD FOR THE MANUFACTURING OF DELMOPINOL INTERMEDIATES LUNDBECK PHARMACEUTICALS ITALY S.P.A. (IT) 2018-06-28 WO disclosed
EP-0225808-B1 PROCESS FOR PREPARING IMPROVED HIGH SOLIDS ACRYLIC-BASED COATINGS EXXON CHEMICAL PATENTS INC. (US) 1993-04-28 EP disclosed
US-5034154-A Solvents for hydroxy substituted alkyl acrylates EXXON CHEMICAL PATENTS INC. (US) 1991-07-23 US disclosed
EP-0207776-B1 TRACTION DRIVE FLUID NIPPON OIL CO. LTD. (JP) 1990-12-19 EP disclosed
US-4859310-A DESALTING, FLASHING, CATALYST REGENERATION AMOCO CORPORATION (US) 1989-08-22 US disclosed
US-4758642-A Process for preparing improved high solids acrylic-based coatings EXXON CHEMICAL PATENTS INC. (US) 1988-07-19 US disclosed
US-4675459-A Traction drive fluid NIPPON OIL COMPANY, LTD. (JP) 1987-06-23 US disclosed
EP-0225808-A2 Process for preparing improved high solids acrylic-based coatings EXXON CHEMICAL PATENTS INC. (US) 1987-06-16 EP disclosed
EP-0207776-A2 Traction drive fluid NIPPON OIL CO. LTD. (JP) 1987-01-07 EP disclosed
US-3969196-A Process for the separation of mixtures of substances STUDIENGESELLSCHAFT KOHLE M.B.H. (DT) 1976-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10894778-B2 Method for the manufacturing of delmopinol THOP1, IGF2BP2, IGF2BP3 CES2 1092/4885CES1 1228/4885FFAR3 1992/4885
US-20210130307-A1 METHOD FOR THE MANUFACTURING OF DELMOPINOL INTERMEDIATES THOP1, PTMS, NISCH CES2 911/4885CES1 1333/4885FFAR3 1810/4885
US-11384056-B2 Method for the manufacturing of delmopinol intermediates THOP1, PTMS, CYP4A11 CES2 942/4885CES1 1313/4885FFAR3 1597/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.